Canagliflozin Tablets

RLD used is Crestor and product is being developed for Europe and Emerging nations

RLD used is Mylan's Saxagliptin. Product is available for Emerging countries. 

RLD is Renvela (Genzyme). It is open for outlicensing for EU, Canada, Australia and Emerging countries. 

RLD is Renvela (Genzyme). It is open for outlicensing for EU, Canada, Australia and Emerging countries. 

RLD used is Pico- Salax for oral solution by Fering. This product is being developed for Europe. Product is available for outlicensing for EU, SEA, LATAM, CIS regions. 

Meets the RLD Heptral

Under development, The RLD used is Vraylar

Deferasirox Sprinkle granules were developed to improve palatability and patient adherence.
and it is in compliance to EU RLD Jadenu

RLD used is Zithromax (Pfizer). Product is been developed for Emerging nations. 

The API will be used for the development of generic version of Desferal injection 

SRS Life Sciences Pte ltd offers a wide range of products which includes Cefuroxime Axetil. It belongs to ANTIBIOTICS AND ANTIBACTERIALS category. Form: Dry Powder Suspension. Strength: 125mg, 250mg. Pack Type: Sachets. Packing Style: 10's. Contact us for more information.

Ertugliflozin tablets, marketed under the brand names STEGLATRO, STEGLUJAN, and SEGLUROMET, is still under development.

Rajah Dubey, Chief Technical Strategist of SRS Life Sciences, speaks with CPHI TV at CPHI Worldwide in Madrid.